Tag: COVID-19

The Productivity Commission has unveiled its 50th annual Trade and Assistance Review (TAR), detailing the amount of industry assistance provided by the Australian Government for the 2022-23 fiscal year.

Global medical technology company Moderna has appointed Emma Harrington as the inaugural manufacturing site head for the company’s new mRNA vaccine manufacturing site in Australia. 

Victoria is one step closer to locally manufacturing mRNA vaccines and medicines, with the construction of Moderna’s mRNA vaccine manufacturing facility reaching the halfway mark, progressing faster than originally planned.

The Anticipating Future Skills Series from Jobs Queensland has released four headline employment forecasts for the five-year period 2025-26, estimating total employment of nearly three million, an increase of 207,000 new jobs.

The Productivity Commission’s 2023 Bulletin has revealed that the 4.6 per cent fall in labour productivity for the 12 months to March 2023 is brought about by the unwinding of COVID-19-related effects and historically low unemployment rate.

Researchers from the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland have developed powdery "nanoprobes" from baker's yeast that may one day be used to quickly and cheaply identify viruses in an environment.

Australia biotechnology company Vaxxas said it achieved positive interim results from a Phase I human clinical trial with the first needle-free COVID-19 vaccine candidate. 

Australia's job vacancies dropped in the three months leading up to February, the third consecutive quarter of decline, but figures remain significantly higher than levels prior to the pandemic, indicating a competitive labour market, according to the latest Australian Bureau of Statistics (ABS) data.

Government statutory agency Safe Work Australia (SWA) has issued a new report illustrating the effects of the COVID-19 pandemic on workers returning to work following an injury or illness.

Australian biotech company Noxopharm Limited unveiled today the development of a new mRNA vaccine enhancer that will make mRNA vaccines safer by reducing inflammation associated with mRNA vaccines.